NCT03822351 · Interventional trial
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Overall registry status Completed
Phase 2
Conditions Stage III Non-small Cell Lung Cancer, Unresectable
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory